) as the recipient. Selection of transconjugants was made on MacConkey agar plates containing rifampin (100 g/ml) and ceftazidime (2 to 4 g/ml). Plasmid isolation was performed using the ChargeSwitch Plasmid ER minikit (Invitrogen Corporation, Carlsbad, CA) and a standard alkaline lysis protocol, using E. coli 39R861 as the standard plasmid control. Restriction fragment length polymorphism (RFLP) of the plasmid extract of E. coli strain 28 and the transconjugant derived from Klebsiella pneumoniae 2873 carrying VIM-12 in plasmid p2873 (6) was performed using BamHI. The location of the bla VIM gene was determined as described previously (3) by Southern blotting of unsheared genomic DNA, followed by gene-specific hybridization using a digoxigeninlabeled bla VIM-1 probe (7).
E. coli strain 28 was susceptible to imipenem and meropenem (MICs, 1 and 0.25 g/ml, respectively), aztreonam, ciprofloxacin, and cotrimoxazole but resistant to all other antimicrobials tested ( Table 1 ). The presence of MBL was indicated by positive DDST and Etest MBL. PCR for ␤-lactamase genes showed that E. coli strain 28 was positive for bla VIM and bla CMY/LAT genes but negative for the remaining genes. PCR assays using primers 5ЈCS and 3ЈCS in various combinations with primers bla VIM and aacA and nucleotide sequencing revealed an integron structure identical with that of integron In-h12, originally found in the bla VIM-12 -producing K. pneumoniae (GenBank accession number DQ143913) (6) .
Repeated mating experiments yielded, at a median frequency of 1.8 ϫ 10
Ϫ2 per donor cell, transconjugant colonies that had elevated MICs of penicillins, cephalosporins, and aminoglycosides but not of carbapenems and tetracycline (Table 1). Plasmid analysis of both clinical and transconjugant colonies showed a single plasmid of approximately 70 kb. PCR specific for bla VIM and bla CMY/LAT in several transconjugant colonies was positive only for the latter gene. RFLP analysis with BamHI showed that the conjugative plasmid of E. coli strain 28 had a different restriction pattern from that of p2873 (6), tested in parallel. The location of In-h12 in the chromosome was indicated by hybridization of the unsheared genomic DNA with the bla VIM-1 probe.
Production of VIM-12, a VIM-1/VIM-2 hybrid MBL, is documented here for the first time for an E. coli isolate after its original detection in K. pneumoniae. It is noteworthy that several bla VIM-12 -producing K. pneumoniae strains have been identified in the same hospital since the original detection in 2005 (unpublished data), indicating a rather wide dissemination of this gene among our K. pneumoniae isolates. E. coli strain 28 carried an integron identical to In-h12, although not lying in the transferable plasmid p2873, which harbored bla VIM-12 in K. pneumoniae (6) . It could be speculated here that the integron In-h12 containing the bla VIM-1/VIM-2 hybrid gene bla VIM-12 has arisen within our hospital settings, where bla VIM-1 -and bla VIM-2 -carrying gram-negative pathogens are common (1, 2, 4, 7) . Alternatively, the bla VIM-12 gene might be independent and have a wide natural distribution in bacterial populations, as was observed previously for other bla VIM genes (8). a CLA, clavulanic acid (2 g/ml); TZB, tazobactam (4 g/ml).
